TGFB1 and breast cancer: Although in P1 tumorspheres, celecoxib had little effect on TGFβ-induced tumorsphere formation, it significantly suppressed the TFE of TGFβ-treated basal breast cancer cells in P2 tumorspheres (Fig. 5a,b).